Alnylam and Sanofi Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. IRT
8. QCOM
9. AEO
10. MSI

Go back to Alnylam and Sanofi Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 258.00 -2.1 (0.81%)
Previous Close $260.10    52 Week High $109.10 
Open $257.07    52 Week Low $31.38 
Day High $261.98    P/E N/A 
Day Low $253.28    EPS $-1.45 
Volume 1,409,014       

GENZYME (NASDAQ: GENZ) Delayed: 37.94 -0.82 (2.12%)
Previous Close $38.76    52 Week High $76.48 
Open $38.54    52 Week Low $65.50 
Day High $38.54    P/E 316.17 
Day Low $37.94    EPS $0.12 
Volume 620       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.68 -0.18 (1.21%)
Previous Close $14.86    52 Week High $5.58 
Open $14.59    52 Week Low $3.60 
Day High $14.72    P/E N/A 
Day Low $14.54    EPS $0.00 
Volume 5,905,870       

SANOFI (NASDAQ: SNY) Delayed: 42.85 -0.3 (0.7%)
Previous Close $43.15    52 Week High $44.76 
Open $43.08    52 Week Low $36.81 
Day High $43.46    P/E N/A 
Day Low $42.82    EPS $0.00 
Volume 1,946,764